Copenhagen, Denmark

Korbinian Löbmann

This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignee: Dispersome IP Aps. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Korbinian Löbmann. Retrieved from https://idiyas.com/inventor/korbinian-lobmann-8hdnegpl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Korbinian Löbmann: Innovator in Pharmaceutical Compositions

Introduction

Korbinian Löbmann is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on co-amorphous forms of drug substances.

Latest Patents

Löbmann holds a patent for "Co-amorphous forms of beta-lactoglobulin and a drug substance." This invention relates to co-amorphous forms of a drug substance and a protein, specifically beta-lactoglobulin, with a purity of at least 92% (w/w) of the total amount of protein in the co-amorphous form. The patent also covers compositions, including pharmaceutical formulations, that utilize this co-amorphous form.

Career Highlights

Throughout his career, Löbmann has worked with various companies, including Dispersome IP Aps and Zerion Pharma Aps. His expertise in the pharmaceutical industry has allowed him to develop innovative solutions that enhance drug delivery and efficacy.

Collaborations

Löbmann has collaborated with notable professionals in his field, including Ole Wiborg and Donglei Leng. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Korbinian Löbmann's work in the realm of pharmaceutical compositions showcases his innovative spirit and dedication to improving drug formulations. His contributions are significant in the ongoing evolution of pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…